Chengdu Kanghong Pharmaceutical Group Co., Ltd engages in the research, development, manufacture, and sale of pharmaceuticals and medical devices in China. It develops medicines for ophthalmic, neuropsychiatric, and others. The company was founded in 1996 and is headquartered in Chengdu, China.
Research context
Chengdu Kanghong Pharmaceuticals Group Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 7 months ago
Chengdu Kanghong Pharmaceuticals Group Co., Ltd is currently in a long term downtrend where the price is trading 37.3% below its 200 day moving average.
From a valuation standpoint, the stock is 20.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.7.
Chengdu Kanghong Pharmaceuticals Group Co., Ltd's total revenue rose by 12.6% to $955M since the same quarter in the previous year.
Its net income has increased by 47.3% to $244M since the same quarter in the previous year.
Finally, its free cash flow grew by 1952.3% to $395M since the same quarter in the previous year.
Based on the above factors, Chengdu Kanghong Pharmaceuticals Group Co., Ltd gets an overall score of 4/5.